MedPath

Effect of Virechana with Trivrit Modak and orally Shalmali Ghrita in abnormal menstrual bleeding

Phase 2
Conditions
Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle
Registration Number
CTRI/2022/09/045516
Lead Sponsor
niversity Post Graduate Institute Of Ayurved Studies and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Excessive bleeding

2)Prolonged menstruation

3)Intermenstrual bleeding

4)Willingness of patients.

5)Patients who are Yogya for Virechan. (Decided by according to Dosha, Aushadh, Desha, kala, Satmaya, Agni Satva, Vaya, Bala, etc.)

Exclusion Criteria

1)Bleeding due to erosion, fibroid & Polyp.

2)Patients having bleeding due to abortion.

3)Bleeding from the site other than the uterus.

4)Patients having Coagulation disorders.

5)Patient suffering from malignancies and chronic systemic diseases like, uncontrolled diabetes (above the range of 160-200 mg/dl), uncontrolled hypertension (Systolic blood pressure <180 & diastolic blood pressure <120mm hg).

�Patients having STDs like Gonorrhoea, Syphilis, HIV/AIDS.

�Patients using IUCD and Oral contraceptive pills (OCP)

�Patients who are Ayogya for Virechana.

�Patients having Hemoglobin less than 7.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath